United States · FDA National Drug Code directory
Terazosin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66267-389_1fa6d444-4cb4-0343-e063-6394a90aa95a
- Product NDC
- 66267-389
- Form
- CAPSULE
- Composition / generic term
- Terazosin Hydrochloride
- Labeler
- NuCare Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20041220
- Source listing expiry
- 20261231
Source-listed ingredients
- TERAZOSIN HYDROCHLORIDE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 CAPSULE in 1 BOTTLE (66267-389-90) · 66267-389-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →